Uralochka, держись! Если нужна помощь, то дай знать.

Насчет лечения для экземы. Нашла статью про местные иммуномудуляторы, пимекролимус. В США известен под названием Elidel. Широко применяется в Великобритании сейчас. Безопасен в любых кол-ах хорошо помогает и предотвращает будущие flare ups. Я вот думаю, если это правда, то почему его не назначают здесь вместо стероидных кремов? Надо врачу завтра позвонить спросить про это дело.

The FDA has issued a public health advisory to inform healthcare professionals and patients about a potential cancer risk from use of Elidel (pimecrolimus). This concern is based on information from animal studies, case reports in a small number of patients, and knowledge of how drugs in this class work. It may take human studies of ten years or longer to determine if use of Elidel is linked to cancer. In the meantime, this risk is uncertain, and FDA advises Elidel should be used only as labeled, for patients after other prescription treatments have failed to work or cannot be tolerated.
Recommendations

Physicians with patients using Elidel, or who are considering prescribing the drug, should consider the following:

Use Elidel only as second-line agent for short-term and intermittent treatment of atopic dermatitis, a form of eczema, in patients unresponsive to, or intolerant of other treatments.

Avoid use of Elidel in children younger than 2 years of age. The effect of Elidel on the developing immune system in infants and children is not known. In clinical studies, infants and children younger than 2 years old treated with Elidel had a higher rate of upper respiratory infections than those treated with placebo cream.

Use Elidel only for short periods of time, not continuously. The long term safety of Elidel is unknown.

Children and adults with a weakened or compromised immune system should not use Elidel.

Use the minimum amount of Elidel needed to control the patient’s symptoms. In animals, increasing the dose resulted in higher rates of cancer.